TPD Assay Development & Screening Summit

by Stephen Riddle

Uniting Technical Personnel to Expand Assay Capabilities for Next Generation Protein Degraders

Bringing together technical expertise sharing case studies with actionable insights, the Inaugural TPD Assay Development & Screening Summit has been established as the first and only industry-dedicated conference to support in-house assay development and screening strategies to find new targets, uncover novel ligands, drive down costs and progress from early discovery to drug candidate with scalable compounds.

With new technologies such as CryoEM and DNA encoded libraries showing promise, join us as we take a deep dive into the key challenges holding back the progression of candidates into pre-clinical studies by determining the best technologies and methodologies for your programs.

Expert speaking companies include Plexium, Stanford University Medical School, Seed Therapeutics, Janssen Pharmaceutical Companies of Johnson & Johnson, Kymera Therapeutics, Foghorn Therapeutics & many more.

View the full event guide here.

This post was originally published on Source Link

You may also like